12,233 Shares in Pro-Dex, Inc. (NASDAQ:PDEX) Acquired by Ritholtz Wealth Management

Ritholtz Wealth Management bought a new position in Pro-Dex, Inc. (NASDAQ:PDEX) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 12,233 shares of the medical instruments supplier’s stock, valued at approximately $572,000. Ritholtz Wealth Management owned 0.38% of Pro-Dex at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of PDEX. JPMorgan Chase & Co. lifted its holdings in shares of Pro-Dex by 2.2% in the third quarter. JPMorgan Chase & Co. now owns 24,790 shares of the medical instruments supplier’s stock valued at $740,000 after buying an additional 529 shares during the period. Renaissance Technologies LLC raised its position in Pro-Dex by 7.9% in the second quarter. Renaissance Technologies LLC now owns 12,240 shares of the medical instruments supplier’s stock worth $240,000 after acquiring an additional 900 shares in the last quarter. FMR LLC lifted its holdings in Pro-Dex by 34.9% in the 3rd quarter. FMR LLC now owns 3,973 shares of the medical instruments supplier’s stock valued at $119,000 after acquiring an additional 1,028 shares during the last quarter. Bard Associates Inc. boosted its position in shares of Pro-Dex by 17.6% during the 3rd quarter. Bard Associates Inc. now owns 13,596 shares of the medical instruments supplier’s stock valued at $406,000 after purchasing an additional 2,031 shares in the last quarter. Finally, Geode Capital Management LLC grew its stake in shares of Pro-Dex by 9.1% in the 3rd quarter. Geode Capital Management LLC now owns 27,435 shares of the medical instruments supplier’s stock worth $819,000 after purchasing an additional 2,296 shares during the last quarter. 15.28% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Pro-Dex news, CFO Alisha Charlton sold 1,000 shares of Pro-Dex stock in a transaction dated Thursday, November 7th. The stock was sold at an average price of $40.02, for a total transaction of $40,020.00. Following the transaction, the chief financial officer now owns 15,339 shares of the company’s stock, valued at $613,866.78. The trade was a 6.12 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Raymond E. Cabillot sold 3,624 shares of the stock in a transaction that occurred on Monday, January 13th. The stock was sold at an average price of $46.66, for a total transaction of $169,095.84. Following the completion of the sale, the director now directly owns 356,022 shares of the company’s stock, valued at $16,611,986.52. This trade represents a 1.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 14,523 shares of company stock worth $657,266 over the last 90 days. 47.50% of the stock is owned by company insiders.

Pro-Dex Price Performance

PDEX stock opened at $44.35 on Tuesday. Pro-Dex, Inc. has a one year low of $16.18 and a one year high of $59.60. The firm has a 50-day moving average of $48.26 and a two-hundred day moving average of $33.06. The firm has a market capitalization of $144.54 million, a PE ratio of 28.80 and a beta of 0.56. The company has a current ratio of 3.41, a quick ratio of 1.94 and a debt-to-equity ratio of 0.36.

Analysts Set New Price Targets

PDEX has been the subject of several recent research reports. StockNews.com raised shares of Pro-Dex from a “buy” rating to a “strong-buy” rating in a research note on Saturday, December 14th. Ascendiant Capital Markets increased their price objective on Pro-Dex from $30.00 to $52.00 and gave the company a “buy” rating in a research report on Monday, November 11th.

Pro-Dex Profile

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.